0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Recent Results in Cancer Research: Nomenclature, Methodology and Results of Clinical Trials in Acute Leukemias,

DENIS R. MILLER, MD
Am J Dis Child. 1974;128(5):748. doi:10.1001/archpedi.1974.02110300158032.
Text Size: A A A
Published online

ABSTRACT

Before the era of chemotherapy in acute lymphoblastic leukemia (ALL), the median survival time from diagnosis to death was approximately three to four months. Modern regimens employing combination chemotherapy and prophylactic central nervous system therapy are now capable of inducing complete remission in about 90% of children with ALL and approximately 20% to as many as 50% of patients are alive without hematologic or extramedullary relapse for five or more years following diagnosis. Despite the improved outlook, long-term remission and survival for all patients with ALL is still the elusive goal of hematologists and oncologists. It is now recognized that the variability in prognosis may be related to the interaction of specific host, disease, and treatment factors and that certain prognostic features, identifiable at diagnosis, are the key determinants of short- or long-term survival. This book, the proceedings of a workshop held in June 1972 at the Centre National de

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();